ProSciento is a leading specialized clinical research organization (CRO) that focuses on metabolic diseases such as NASH, diabetes, and obesity. With a science-driven approach, ProSciento is dedicated to improving the lives of patients through research and therapeutic development. Known for our proven leadership in metabolic research, our team of science-driven experts is highly regarded for their contributions to the field.

We have deep connections with clients and partners, ensuring quality results and advancements in science. Our specialized clinical research services provide broad scientific expertise, direct patient access, and advanced methodologies. We are exclusively focused on diabetes, NASH, and obesity, supporting our clients' commitment to improving human health.

Our understanding of metabolic disease and the specific research methods and processes to accelerate drug and device development are proven and measurable. At ProSciento, our unwavering commitment is to the patients who can benefit from the clinical research programs we conduct. With a team of passionate scientists and operational experts, we strive to develop life-changing therapeutics that improve their lives.

ProSciento: Science-driven. Focused. Dedicated